Role of asymmetric methylarginine and connexin 43 in the regulation of pulmonary endothelial function

Pulmonary Circulation

Volumn 3, Issue 3, 2013, Pages 675-691

  Tsang, Hilda ^a   Leiper, James ^a   Lao, Ka Hou ^a   Dowsett, Laura ^a   Delahaye, Matthew W ^a   Barnes, Gareth ^a,b   Wharton, John ^a   Howard, Luke ^b   Iannone, Lucio ^a   Lang, Ninian N ^c   Wilkins, Martin R ^a   Wojciak Stothard, Beata ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Angiogenesis; Endothelial cells; Nitric oxide; Pulmonary hypertension

Indexed keywords

EID: 84978174037     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/674440     Document Type: Article

References (30)

1. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-165.
2. Pullamsetti S, Kiss L, Ghofrani HA, et al. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. FASEB J 2005;19:1175-1177.
3. Leiper J, Nandi M, Torondel B, et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 2007;13:198-203.
4. Wojciak-Stothard B, Torondel B, Zhao L, Renne T, Leiper JM. Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function. Mol Biol Cell 2009; 20:33-42.
5. Millatt LJ, Whitley GS, Li D, et al. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Circulation 2003; 108:1493-1498.
6. Fiedler LR, Bachetti T, Leiper J, et al. The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis. Arterioscler Thromb Vasc Biol 2009;29:2117-2124.
7. Jia SJ, Zhou Z, Zhang BK, Hu ZW, Deng HW, Li YJ. Asymmetric dimethylarginine damages connexin43-mediated endothelial gap junction intercellular communication. Biochem Cell Biol 2009;87:867-874.
8. Reaume AG, de Sousa PA, Kulkarni S, et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995; 267:1831-1834.
9. Simon AM, McWhorter AR. Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 2002;251:206-220.
10. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-1809.
11. Wojciak-Stothard B, Torondel B, Tsang LYF, et al. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility. J Cell Sci 2007;120:929-942.
12. Hu X, Atzler D, Xu X, et al. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Arterioscler Thromb Vasc Biol 2011;31:1540-1546.
13. Tilghman RW, Hoover RL. E-selectin and icam-1 are incorporated into detergent-insoluble membrane domains following clustering in endothelial cells. FEBS Lett 2002;525:83-87.
14. Julià E, Edo MC, Horga A, Montalban X, Comabella M. Differential susceptibility to apoptosis of CD4+T cells expressing CCR5 and CXCR3 in patients with MS. Clin Immunol 2009; 133:364-374.
15. Pilz RB, Suhasini M, Idriss S, Meinkoth JL, Boss GR. Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J 1995;9: 552-558.
16. Mitchell JA, Lye SJ. Differential activation of the connexin 43 promoter by dimers of activator protein-1 transcription factors in myometrial cells. Endocrinology 2005;146:2048-2054.
17. Wang HH, Kung CI, Tseng YY, et al. Activation of endothelial cells to pathological status by down-regulation of connexion 43. Cardiovasc Res 2008;79:509-518.
18. Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc Res 2004;62:233-245.
19. Walker DL, Vacha SJ, Kirby ML, Lo CW. Connexin43 deficiency causes dysregulation of coronary vasculogenesis. Dev Biol 2005;284:479-498.
20. Gairhe S, Bauer NN, Gebb SA, McMurtry IF. Myoendothelial gap junctional signaling induces differentiation of pulmonary arterial smooth muscle cells. AmJ Physiol 2011;301:L527-L535.
21. Gairhe S, Bauer NN, Gebb SA, McMurtry IF. Serotonin passes through myoendothelial gap junctions to promote pulmonary arterial smooth muscle cell differentiation. Am J Physiol 2012;303:L767-L777.
22. O’Quinn MP, Palatinus JA, Harris BS, Hewett KW, Gourdie RG. A peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling and induced arrhythmia following ventricular injury. Circ Res 2011;108:704-715.
23. Lang NN, Myles RC, Burton FL, et al. The vascular effects of rotigaptide in vivo in man. Biochem Pharmacol 2008;76: 1194-1200.
24. Axelsen LN, Haugan K, Stahlhut M, et al. Increasing gap junctional coupling: a tool for dissecting the role of gap junctions. J Membr Biol 2007;216:23-35.
25. Pedersen CM, Lang N, Venkatasubramanian S, et al. Augmentation of connexin-43 conductance reduces ischemia-reperfusion injury and myocardial infarct size. Circulation 2012;126:A11360.
26. Axelsen LN, Stahlhut M, Mohammed S, et al. Identification of ischemia-regulated phosphorylation sites in connexin43: a possible target for the antiarrhythmic peptide analogue rotigaptide (zp123). J Mol Cell Cardiol 2006;40:790-798.
27. Jeyaraman MM, Srisakuldee W, Nickel BE, Kardami E. Connexin43 phosphorylation and cytoprotection in the heart. Biochim Biophys Acta 2012;1818:2009-2013.
28. 2+-dependent proinflammatory responses in lung capillaries. J Clin Invest 2006;116:2193-2200.
29. Toshner M, Voswinckel R, Southwood M, et al. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. AmJ Respir Crit Care Med 2009;180:780-787.
30. Duong HT, Comhair SA, Aldred MA, et al. Pulmonary artery endothelium resident endothelial colony-forming cells in pulmonary arterial hypertension. PulmCirc 2011;1:475-486